TCT-488 Risk of stent thrombosis with 6 vs. 12 months dual antiplatelet therapy after new generations drug-eluting stents implantation: final results of the multicenter prospective ESTROFA-DAPT study

Patients to include should meet at least one of the following criteria: silent ischemia, stable angina, low risk acute coronary syndrome (ACS) or any ACS with no-low bleeding risk.

Saved in:

Bibliographic Details
Published in:	Journal of the American College of Cardiology Vol. 64; no. 11; p. B144
Main Authors:	De la Torre Hernandez, Jose M, Oteo Dominguez, Juan F, Hernandez, Felipe, Camarero, Tamara Garcia, Abdul-Jawad Altisent, Omar, Rivero-Crespo, Fernando, Cascon, Jose D, Zavala, German, Gimeno, Federico, Arrebola-Moreno, Antonio L, Andraka, Leire, Menchero, Antonio Gomez, Bosa, Francisco, Carrillo, Xavier, Sanchez-Recalde, Angel, Alfonso, Fernando, Pérez de Prado, Armando, Palop, Ramon Lopez, Sanchis, Juan, Diarte de Miguel, José A, De Lemos, Rocio, Muñoz, Luz, Moreno, Antonio Ramirez, Tizon-Marcos, Helena
Format:	Journal Article
Language:	English
Published:	New York Elsevier Inc 16-09-2014 Elsevier Limited
Subjects:	Acute coronary syndromes Angina pectoris Cardiology Cardiovascular Internal Medicine Thrombosis
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Patients to include should meet at least one of the following criteria: silent ischemia, stable angina, low risk acute coronary syndrome (ACS) or any ACS with no-low bleeding risk.
ISSN:	0735-1097 1558-3597
DOI:	10.1016/j.jacc.2014.07.543